High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$39.0M
$39,008,150
Total Sells (Filtered)
$503M
$503,545,000
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
COGT
S
Cogent Biosciences, Inc.
Fairmount Funds Management LLC
• Director
Discretionary SellΔOwn -56.0%
2026-03-31
$242,620,000MEGA
|
||||||
| COGT |
Cogent Biosciences, Inc.
|
Director
Discretionary SellΔOwn -56.0%
|
2026-03-31 | $242,620,000MEGA | S | Form 4 |
|
ZBIO
P
Zenas BioPharma, Inc.
Fairmount Funds Management LLC
• Director
Discretionary Buy
2026-03-31
$3,000,000Large
|
||||||
| ZBIO |
Zenas BioPharma, Inc.
|
Director
Discretionary Buy
|
2026-03-31 | $3,000,000Large | P | Form 4 |
|
COGT
S
Cogent Biosciences, Inc.
Fairmount Funds Management LLC
• Director
Discretionary SellΔOwn -38.9%
2026-01-22
$127,400,000MEGA
|
||||||
| COGT |
Cogent Biosciences, Inc.
|
Director
Discretionary SellΔOwn -38.9%
|
2026-01-22 | $127,400,000MEGA | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Fairmount Funds Management LLC
• Director
Discretionary SellΔOwn -85.4%
2026-01-22
$133,525,000MEGA
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Director
Discretionary SellΔOwn -85.4%
|
2026-01-22 | $133,525,000MEGA | S | Form 4 |
|
CBIO
P
CRESCENT BIOPHARMA, INC.
Fairmount Funds Management LLC
• Director
Discretionary BuyΔOwn +98.0%
2025-12-04
$18,237,600MEGA
|
||||||
| CBIO |
CRESCENT BIOPHARMA, INC.
|
Director
Discretionary BuyΔOwn +98.0%
|
2025-12-04 | $18,237,600MEGA | P | Form 4 |
|
CBIO
P
CRESCENT BIOPHARMA, INC.
Fairmount Funds Management LLC
• Director
Discretionary Buy
2025-12-04
$1,762,399Large
|
||||||
| CBIO |
CRESCENT BIOPHARMA, INC.
|
Director
Discretionary Buy
|
2025-12-04 | $1,762,399Large | P | Form 4 |
|
VRDN
P
Viridian Therapeutics, Inc.\DE
Fairmount Funds Management LLC
• Director
Discretionary BuyΔOwn +13.1%
2025-10-23
$9,999,990Whale
|
||||||
| VRDN |
Viridian Therapeutics, Inc.\DE
|
Director
Discretionary BuyΔOwn +13.1%
|
2025-10-23 | $9,999,990Whale | P | Form 4 |
|
ZBIO
P
Zenas BioPharma, Inc.
Fairmount Funds Management LLC
• Director
Discretionary BuyΔOwn +16.7%
2025-10-07
$6,008,161Whale
|
||||||
| ZBIO |
Zenas BioPharma, Inc.
|
Director
Discretionary BuyΔOwn +16.7%
|
2025-10-07 | $6,008,161Whale | P | Form 4 |